Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

John Golubieski Biography and Net Worth

CFO & Chief Accounting Officer of BioDelivery Sciences International

John Golubieski is the CFO & Chief Accounting Officer at Biodelivery Sciences International.

How old is John Golubieski?: Mr. Golubieski is currently 57 years old. There are 3 older executives and no younger executives at BioDelivery Sciences International. The oldest executive at BioDelivery Sciences International is Dr. Thomas B. Smith FAAFP, M.D., Chief Medical Officer, who is 61 years old. Learn More on John Golubieski's age.
How do I contact John Golubieski?: The corporate mailing address for Mr. Golubieski and other BioDelivery Sciences International executives is 4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC, 27612. BioDelivery Sciences International can also be reached via phone at (919) 582-9050 and via email at [email protected]. Learn More on John Golubieski's contact information.
Has John Golubieski been buying or selling shares of BioDelivery Sciences International?: John Golubieski has not been actively trading shares of BioDelivery Sciences International within the last three months. Learn More on John Golubieski's trading history.
Who are BioDelivery Sciences International's active insiders?: BioDelivery Sciences International's insider roster includes John Golubieski (CFO & Chief Accounting Officer ), Kevin Kotler (Director), Mark Sirgo (Director), and James Vollins (Insider). Learn More on BioDelivery Sciences International's active insiders.

John Golubieski Insider Trading History at BioDelivery Sciences International

John Golubieski Buying and Selling Activity at BioDelivery Sciences International

BioDelivery Sciences International Company Overview

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

Today's Range

Now: $5.59

$5.59

$5.60

50 Day Range

MA: $5.58

$5.54

$5.60

2 Week Range

Now: $5.59

$2.50

$5.62

Volume

2,090,567 shs

Average Volume

3,340,554 shs

Market Capitalization

$577.05 million

P/E Ratio

6.74

Dividend Yield

N/A

Beta

0.56